Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	41.78	9.7	0.46	16.58	-	0.02
Cash & Short-Term Investments	41.78	9.7	0.46	16.58	-	0.02
Cash Growth	122.02%	2032.09%	-97.26%	-	-	-40.00%
Prepaid Expenses	1.68	3.37	2.03	1.71	-	0
Other Current Assets	0.59	0.33	0.16	0.13	0.2	-
Total Current Assets	44.05	13.4	2.64	18.41	0.2	0.02
Property, Plant & Equipment	0.65	0.79	0.17	0.33	-	-
Total Assets	44.7	14.19	2.82	18.74	0.2	0.02
Accounts Payable	1.47	0.84	0.89	0.74	0.18	0.32
Accrued Expenses	3.12	3.23	2.24	1.21	0.18	0.12
Short-Term Debt	-	-	-	-	2.51	0.46
Current Portion of Leases	0.36	0.33	0.16	0.15	-	-
Other Current Liabilities	8.13	13.13	-	-	-	-
Total Current Liabilities	13.09	17.53	3.28	2.11	2.88	0.9
Long-Term Leases	0.27	0.47	-	0.16	-	-
Total Liabilities	13.36	18	3.28	2.26	2.88	0.9
Common Stock	0.04	0.04	0.02	0.02	0.01	0.04
Additional Paid-In Capital	60.76	60.7	33.52	32.41	3.24	2.74
Retained Earnings	-75.65	-64.54	-34	-15.94	-5.92	-3.66
Shareholders' Equity	31.34	-3.81	-0.47	16.48	-2.67	-0.88
Total Liabilities & Equity	44.7	14.19	2.82	18.74	0.2	0.02
Total Debt	0.63	0.79	0.16	0.31	2.51	0.46
Net Cash (Debt)	41.15	8.91	0.3	16.27	-2.51	-0.45
Net Cash Growth	130.11%	2869.33%	-98.16%	-	-	-
Net Cash Per Share	1.17	0.36	0.02	1.39	-0.30	-0.05
Filing Date Shares Outstanding	94.36	34.76	15.23	15	8.9	8.46
Total Common Shares Outstanding	43.57	34.76	15.23	15	8.51	8.46
Working Capital	30.97	-4.14	-0.64	16.31	-2.67	-0.88
Book Value Per Share	-0.34	-0.11	-0.03	1.10	-0.31	-0.10
Tangible Book Value	-14.85	-3.81	-0.47	16.48	-2.67	-0.88
Tangible Book Value Per Share	-0.34	-0.11	-0.03	1.10	-0.31	-0.10
Machinery	0.05	0.02	0.01	0.01	-	-
Leasehold Improvements	0.02	0.02	0.02	0.02	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.